These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8540031

  • 1. Effect of depletion of class II bright cells on the immunogenicity and stem cell content of human vertebral body bone marrow.
    Kenyon NS, Xu XM, Garcia-Serra A, Ricordi C.
    Transplant Proc; 1995 Dec; 27(6):3419. PubMed ID: 8540031
    [No Abstract] [Full Text] [Related]

  • 2. Automated processing of human vertebral body bone marrow yields preparations with stem cell content similar to that obtained with traditional manual preparation.
    Kenyon NS, Xu XM, Knapp J, Selvaggi GS, Bottino R, Kong SS, Qian T, Linetsky E, Ricordi C.
    Transplant Proc; 1995 Dec; 27(6):3418. PubMed ID: 8540030
    [No Abstract] [Full Text] [Related]

  • 3. Suitability of neonatal vertebral body marrow for transplant applications.
    Kong SS, Selvaggi G, Kenyon N, Knapp J, Olson L, Tzakis AG, Miller J, Ricordi C.
    Transplant Proc; 1995 Dec; 27(6):3416. PubMed ID: 8540028
    [No Abstract] [Full Text] [Related]

  • 4. A simple method for depletion of bone fragments from human vertebral body marrow.
    Kong SS, Selvaggi G, Kenyon N, Bottino R, Linetsky E, Ricordi C.
    Transplant Proc; 1995 Dec; 27(6):3417. PubMed ID: 8540029
    [No Abstract] [Full Text] [Related]

  • 5. Effect of preservation conditions on human vertebral body marrow.
    Kong SS, Kenyon NS, Brendel M, Tzakis AG, Miller J, Ricordi C.
    Transplant Proc; 1995 Dec; 27(6):3415. PubMed ID: 8540027
    [No Abstract] [Full Text] [Related]

  • 6. CD34 positive cell selection by immunomagnetic techniques.
    Bigas A, Amill B, Canals C, Tugues D, García J.
    Prog Clin Biol Res; 1992 Dec; 377():545-51. PubMed ID: 1279723
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
    Roots-Weiss A, Papadimitriou C, Serve H, Hoppe B, Koenigsmann M, Reufi B, Oberberg D, Thiel E, Berdel WE.
    Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. T-cell depletion from allogeneic bone marrow by counterflow centrifugation is not associated with a substantial loss of CD34-positive cells.
    Preijers F, Ruijs P, Schattenberg A, de Witte T.
    Prog Clin Biol Res; 1994 Jun; 389():339-44. PubMed ID: 7535440
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immunogenicity and stem cell content of class II depleted human vertebral body bone marrow.
    Kenyon NS, Xu XM, Garcia-Serra A, Ricordi C.
    Ann N Y Acad Sci; 1995 Dec 29; 770():361-3. PubMed ID: 8597374
    [No Abstract] [Full Text] [Related]

  • 13. Differences in CD34+ cell subpopulations between human bone marrow and "mobilized" peripheral blood as determined with counterflow centrifugal elutriation.
    Chang Q, Harvey K, Akard L, Thompson J, Dugan MJ, English D, Jansen J.
    Exp Hematol; 1997 May 29; 25(5):423-31. PubMed ID: 9168064
    [Abstract] [Full Text] [Related]

  • 14. A manual method for processing bone marrow using percoll: characteristics of the transfusion product.
    Glasser L, Smith DM, Fiederlein RL, Wood M.
    Prog Clin Biol Res; 1994 May 29; 389():685-94. PubMed ID: 7700936
    [No Abstract] [Full Text] [Related]

  • 15. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM, Waller EK.
    Biol Blood Marrow Transplant; 2004 Aug 29; 10(8):540-51. PubMed ID: 15282532
    [Abstract] [Full Text] [Related]

  • 16. Processing of bone marrow for transplantation: development of a mononuclear cell enrichment protocol.
    Hollingsworth KL, Williams SF, Blake MS, Pothiawala M, Mick R, Larson RA, Bender JG.
    Prog Clin Biol Res; 1994 Aug 29; 389():695-704. PubMed ID: 7700937
    [No Abstract] [Full Text] [Related]

  • 17. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
    Preijers FW, van Hennik PB, Schattenberg A, Ruijs P, Ploemacher RE, de Witte T.
    Bone Marrow Transplant; 1999 May 29; 23(10):1061-70. PubMed ID: 10373074
    [Abstract] [Full Text] [Related]

  • 18. Development of an anti-porcine CD34 monoclonal antibody that identifies hematopoietic stem cells.
    Layton DS, Strom AD, O'Neil TE, Broadway MM, Stephenson GL, Morris KR, Muralitharan M, Sandrin MS, Ierino FL, Bean AG.
    Exp Hematol; 2007 Jan 29; 35(1):171-8. PubMed ID: 17198886
    [Abstract] [Full Text] [Related]

  • 19. Surgical implantation of bioengineered bone marrow tissue into rats.
    Naughton BA, San Román J, Sibanda B, Weintraub JP, Morales DL, Kamali V.
    Prog Clin Biol Res; 1994 Jan 29; 389():711-25. PubMed ID: 7700939
    [No Abstract] [Full Text] [Related]

  • 20. Induction of allogeneic unresponsiveness in adult dogs by irradiation and bone marrow transplantation: implication of Ia-positive bone marrow stem cells.
    Rapaport FT, Bachvaroff RJ, Asari H, Sato K, Chanana AD, Joel DD, Cronkite EP.
    Ann N Y Acad Sci; 1985 Jan 29; 459():22-5. PubMed ID: 3913369
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.